Patients with Severe Eosinophilic Asthma, CRSwNP More Likely to Achieve Remission with Benralizumab
A post hoc analysis shows benralizumab was even more efficacious in patients with concomitant nasal polyps at both 6 and 12 months.
United States Renaud Louis Linkedin Renaud Louis International Conference American Thoracic Society University Of Liege Department
Source: hcplive.com